Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 09, 2018

SELL
$10.32 - $13.06 $247 - $313
-24 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$7.86 - $11.39 $204 - $296
-26 Reduced 52.0%
24 $0
Q4 2017

Feb 16, 2018

BUY
$8.77 - $12.28 $438 - $614
50
50 $0

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.